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A B S T R A C T
Objective: To explore and describe the perceptions of policy actors and practitioners on antimicrobial use
and resistance in human and animal health in Tanzania.
Methods: This was an exploratory qualitative study, which involved semi-structured interviews with nine
policy makers and 102 practitioners.
Results: Improved multisectoral collaboration and coordination among experts from the animal and
human sectors, government will, improved infrastructures, existence of public awareness campaigns on
appropriate use of antimicrobials and existence of antimicrobial stewardship were identified as strengths
for the implementation of National Action Plan on Antimicrobial Resistance (NAP-AMR) in Tanzania.
Despite these strengths, insufficient public awareness of AMR, limited community engagement and
inadequate human resources were among the reported weaknesses. A number of opportunities for the
implementation of NAP-AMR were also reported including the presence of integrated disease
surveillance and response strategy in health sector and development of a coordinated surveillance
system. Furthermore, the inadequate laboratory capacity and poor resource mobilization were identified
as challenges facing the implementation of NAP-AMR.
Conclusion: The future policies of AMR need to capitalize on the identified strengths and opportunities as
well as design interventions to improve public awareness of AMR and communityengagement, deployment
of adequate human resources and ensure adequate resource mobilization to meet AMR needs.
© 2021 The Authors. Published by Elsevier Ltd on behalf of International Society for Antimicrobial
Chemotherapy. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
1. Background
Antimicrobial resistance (AMR) is now a public health, animal
and ecosystem problem globally. Human activities, including
agriculture, veterinary and human medicine practices, have been
shown to contribute to the evolution and spread of AMR in the
environment [1]. These activities include misuse and overuse of
antimicrobials of variable quality and efficacy in humans and
animals, improper storage and disposal of antimicrobials and
preservatives for food and antibacterial agents in household
products [2,3]. A recent systematic review has indicated that there
are very high levels of antimicrobial use and AMR in animal
production systems in Africa [4]. Regionally, high levels of
antimicrobial use, related weak regulatory measures and poor
AMR surveillance systems are of great concern to animals, the
environment and human health. All these emphasize the call for an
effective holistic and multisectoral collaboration (One Health)
approach, including environmental, animal and public health
sectors, to effectively mitigate this emerging threat.
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t increasing international attention to AMR as a growing public
ealth threat [6]. The WHO policy package recommended several
ctions to be taken by governments to stimulate change and
ddress AMR. These actions include committing to a comprehen-
ive, financed national plan with accountability and civil society
ngagement, strengthening surveillance and laboratory capacity,
nsuring uninterrupted access to essential medicines of assured
uality, and regulating and promoting rational use of medicines
6].
The WHO member states were encouraged to develop National
ction Plans (NAPs) for AMR by 2017 [7]. All these efforts reflect a
lobal recognition and consensus that AMR poses a profound
hreat to human health. However, the effective implementation of
APs faces some challenges, especially in low- and middle-income
ountries (LMICs) [5]. The challenges include: (i) lack of access to
ppropriate antimicrobial therapy; (ii) weak regulation around
ntimicrobial use in humans and animals; (iii) weak surveillance of
ntimicrobial use and resistance levels; (iv) lack of updated
ntimicrobial treatment guidelines; (v) lack of continuing medical/
eterinary education on antimicrobial use for prescribers; (vi) a
eak regulatory framework for the use of antimicrobials in animal
roduction and aquaculture; (vii) tendencies of farmers treating
heir animals without consulting veterinarians; and (viii) livestock
eepers who fail to observe the recommended therapeutic doses
nd withdrawal periods as well as frequently using incorrect
outes of administration [4,8].
Recognizing that antimicrobials play a critical role in the
reatment of diseases of farm animals and plants, the FAO
eveloped the 2016–2020 AMR action plan to support the
HO-led Global Action Plan on Antimicrobial Resistance to assist
ountries to adopt and implement the multisector NAPs to combat
MR. The action plan highlights the critical requirements for
nvolvement of public health and veterinary authorities, the food
nd agriculture sectors, financial planners, environmental special-
sts and consumers in the strategy [9]. However, there is a growing
oncern that resistance to antimicrobial drugs will reverse the
chievements of food safety and animal health [10].
Several studies have demonstrated the magnitude of AMR in
anzania. The prevalence of multidrug-resistant bacteria in clinical
ettings ranges from 25% to 50% [11,12]. A study on AMR among
roducers and non-producers of extended spectrum beta-lacta-
ases in urinary isolates at a tertiary hospital in Tanzania found
MR in both Escherichia coli and Klebsiella species isolates [12].
espite years of global concern and the development of a
omprehensive action plan, AMR in Tanzania has continued to
ncrease in human, animal and environmental sectors. A recent
tudy reported that >70% of all samples from humans and food
nimals contained coliforms that were resistant to cefotaxime,
etracycline, sulfamethoxazole or ampicillin [13]. Despite these
pecific studies, there is limited information on AMR stewardship
n Tanzania. This study was therefore designed to explore and
escribe the policy actors and human and animal health
ractitioners’ perceptions of AMR in Tanzania.
. Methods
.1. Study design and settings
This qualitative study was conducted in the Ilala, Kibaha and
transport infrastructure, dump sites, agriculture, industrial com-
mercial activities, fishing and sand mining [14]. It is highly polluted
by effluents from Msimbazi river tributaries originating from
different sources, leakage of effluent from waste dumps, abattoirs
and domestic wastewater from septic tanks and pit latrines that
are used by ca. 85% of the city population [15]. The area was
appropriate for the study because its population is involved in a
variety of activities, and because of the environmental contami-
nation by effluent and other wastes from different sources, which
can cause one-health AMR infections. Kibaha is characterized by
large- and small-scale poultry [16] and fish farming [17] that is
likely to use antimicrobials. Kilosa district has a large population of
pastoralists keeping cattle who are known to treat their animals
themselves, with frequent use of antimicrobials [18].
2.2. Selection of study participants
We used a purposive sampling strategy to draw the key
informants from each group of actors from the national and health
facility levels in Kilosa, Kibaha and Ilala districts. Policy makers at
the national level were purposively selected from ministries
responsible for public health, livestock, fisheries, food and
agriculture. Other key informants were selected from the national
regulatory authorities and agencies. These key informants were
selected because of their role in the preparation and supervision of
the implementation of the National Action Plan for Antimicrobial
Resistance (NAP-AMR). At the facility level, we purposely selected
key informants including laboratory technologists/technicians,
livestock field officers, agro-vets, in-charges of healthcare facilities,
pharmaceutical assistants and dispensers. An environmental
officer from one of the districts was also interviewed.
2.3. Data collection
An interview with the key national policy actors was conducted
during one of the Multi-Stakeholders Coordination Committee
(MCC) on AMR meetings. The researchers made a presentation in
the meeting, introducing the study goals, objectives and method-
ology to all MCC members. Individual consent was requested and
granted by all members before the interview began. A mapping
exercise was conducted by visiting all three districts to identify a
list of potential key informants (practitioners) under the guidance
of the district officials. Based on the list of key informants
generated from the mapping exercise, we conducted in-depth
interviews with key informants from the health, environment,
livestock and fishing sectors from district and facility levels.
Interviews with practitioners were conducted in Kiswahili, the
national language, lasted 45–90 min and were run by 12 research
assistants trained in qualitative research. All interviews were
conducted face-to-face. Participants were able to choose the
location of the interview, which usually took place at their
workplace.
2.4. Data management and analysis
All interview transcripts were transcribed verbatim and
translated from Kiswahili into English. To avoid loss of the original
meaning, back translation was done for some of the transcripts. We
used a thematic data analysis approach, which applies both
inductive and deductive reasoning. Emerging themes across ailosa districts in Tanzania from June 2019 to February 2020. A
ualitative study design was considered appropriate because
onducting situational analysis on the AMR landscape requires an
n-depth exploration of views from different key informants. Ilala
istrict is in Dar es Salaam City, an urban area, densely populated,
ncorporating multiple activities such as informal housing,4
sample of transcripts were identified and validated by all
researchers before a line-by-line analysis was conducted by two
researchers using NVivo 12 qualitative data analysis software (QSR
International Pty Ltd. Version 12, 2018). The emerging themes
were categorized into strengths, weaknesses, opportunities and
challenges (SWOC) relevant to the AMR landscape in Tanzania.1
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3.1. Study participants
This study involved a total of 111 semi-structured interviews. Of
these, nine were policy actors who were members of the national
Multi-Stakeholders Committee from the Food and Agriculture
Organization of the United Nations Country Office (n = 1), Ministry
of Health, Community Development, Gender, Elderly and Children
(n = 6), Ministry of Livestock and Fisheries (n = 1) and Tanzania
Medicines and Medical Devices Authority (n = 1). In addition, we
interviewed an Environmental officer from Ilala Municipality (n =
1), a pharmacist from Kilosa District Hospital (n = 1) and a member
of implementing partner (n = 1). For practitioners, the interviews
involved 102 individuals who included laboratory technologists/
technicians from public and private primary healthcare facilities
(25), livestock field officers (12), agro-vets (15), in-charges of
health facilities (23), pharmaceutical assistants (8) and dispensers
(19). The study findings are presented based on four main
categories from SWOC analysis and corresponding themes (Fig. 1).
3.2. Strengths
Four main factors were described by participants as strengths to
the response to AMR in Tanzania. These were (i) improved
multisectoral collaboration and coordination of AMR activities
among experts from the animal and human health sectors, (ii)
existence of political will for combatting AMR, (iii) existence of
public awareness campaigns on appropriate use of antimicrobials
and (iv) existence of antimicrobial stewardship. Key informants
reported that improved multisectoral collaboration and coordina-
tion of AMR activities among experts from the human, animal and
environmental health sectors is an important strength for
combatting AMR in Tanzania. According to the national-level
respondents, the One Health approach brings together different
disciplines in all three key sectors, which requires multisectoral
governance to support the coordination of AMR strategies. The key
informants revealed that establishment of a MCC on AMR has been
instrumental in coordinating various activities. Furthermore, it
was reported that the existence of a technical working group on
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he technical working groups, which support coordination of various
echnical AMR activities’ (key informant (KI) 9: MCC member from
AO).
Some national-level respondents claimed that the Tanzanian
overnment is committed to support the efforts toward com-
atting AMR. Political commitment and government leadership
ere reported as critical components to drive the AMR agenda in
erms of coordination of its interventions and mobilization and
llocation of resources: ‘The strength that I currently see is a political
ill, the government has taken this (AMR) seriously; that is why now
e have MCC sessions to coordinate everything that is happening in
he country regarding antimicrobial resistance’ (KI 7: MCC member
rom Tanzania Medicines & Medical Devices Authority). Another
ey informant added: ‘It is because of the government’s commitment
hat the AMR will continue to be implemented’ (KII 8: MCC member
rom American Society of Microbiology — ASM).
Improved infrastructure was reported as one of the strengths
ecessary for combatting AMR. Study respondents reported that
sing a One Health approach through coordinated efforts from
ifferent stakeholders, including government and development
artners, has facilitated an improvement in infrastructural
evelopment through mobilization of resources from different
ectors. Interviewees suggested that through joint efforts some
aboratories were renovated to enable them to provide support in
icrobiological and antibiotic sensitivity services, which in turn
ay help reduce the unnecessary use of antibiotics. One
espondent emphasized that: ‘The laboratories have been renovated
o the extent they enable laboratory staff to provide correct test results
hich relate to the patient as well as by having communication
etween the laboratory staff and clinician to enable the later to
rescribed appropriate medication’ (KI 7: MCC from TMDA).
Furthermore, some key informants reported that data manage-
ent software has been established to capture national AMR data.
uch software allows other national sites to generate data every
onth and feed them into the national system that aggregates the
ata nationwide. Several interviewees mentioned that develop-
ent partners played a role in supporting establishment of AMR
nformation system infrastructure, as emphasized by one of the
ey informants: ‘We have supported procurement of computers; staff
raining in several sentinel sites; and conducted supervision. We have
lso supported provision of internet bundles for the system’ (KII 8:
CC member from ASM).
The findings from our key informants revealed that the
xistence of public awareness campaigns emphasizing sanitation
nd appropriate use of antimicrobials is an important strength in
ombatting AMR in Tanzania. It was noted that the MCC has been
n active platform in raising awareness on the use of antimicrobial
gents and AMR as testified by one of the key informants: ‘In
ovember 2019, we commemorated the World Antimicrobial
wareness Week, which had the key message on antibiotic resistance
nd irrational use of antibiotics. During that day there were T-shirts
or AMR awareness, there were walks, outreach services and meetings
 Dar es Salaam, Morogoro and Dodoma regions, all these aimed at
reating awareness to the community about AMR’ (KI 9: MCC
ember from FAO). In addition, regulatory authorities such as the
anzania Medicine and Medical Devices Authority (TMDA) work
ogether with other stakeholders including students’ associations
o create awareness on AMR in communities and secondary
chools: ‘Community health education has increased from both the
availability of guidelines and existence of regulatory authorities
such as the TMDA, all of which are focused on addressing AMR: ‘We
have standard treatment guidelines, showing which medicine is to be
used for which disease. We have also developed antimicrobial
stewardship guidelines, which will be released soon’ (KI 9: MCC
member from TMDA). Another respondent stated: ‘We have
guidelines that have reached even the dispensary, which is the lowest
level of our health delivery system. It requires anyone writing a
prescription to comply with the guidelines to make sure that there is
appropriate use of medicines to reduce microbial resistance’ (KI 4:
MCC member from the Ministry of Health, Community Develop-
ment, Gender, Elderly and Children (MoHCDGEC)).
In addition, the government through the MoHCDGEC had
developed guidelines and standards on how to manage hospital
waste effectively to prevent and control infections. In emphasiz-
ing this strength, one respondent said: ‘We are now distributing
guidelines and standards to make sure that hospital’s waste is
properly managed to prevent and control infections’ (KI 4:
MoHCDGEC). Other stewardship programmes have been initiated
to combat AMR. These include training of students pursuing
nursing, laboratory, pharmacy and medicines on antimicrobial use
and AMR, to enable them to educate communities about the
issues: ‘We have training programmes whereby nurses and clinicians
are educated on AMR so that when they graduate, they know how to
apply the knowledge in combatting AMR’ (KI 4: MCC from
MoHCDGEC). Another participant reported that: ‘The training
programme is also provided to laboratory technicians to strengthen
their capacity to be able to detect antimicrobial resistance’ (KII 8:
MCC member ASM).
3.3. Weaknesses
The main weaknesses identified included insufficient public
awareness on AMR, limited community engagement in AMR
activities, weak sectoral or departmental cooperation and inade-
quate human resources. Our analysis identified insufficient public
awareness as one of the main weaknesses in combatting AMR.
Interviewees expressed the concern that even though there is an
improved level of awareness of AMR, to a great extent there is
insufficient awareness among some of the key stakeholders. For
instance, in some regions, districts and communities, antimicrobial
use and AMR awareness is limited, which affects any efforts made
toward combatting it. One of the key informants said: ‘I have never
heard people talking about the impact of antimicrobial resistance to
humans. I have never even seen it on the television. Many people are
not aware of the issue of antibiotics resistance’ (KI 16: in-charge of
dispensary).
According to some respondents from the facility level, there is a
lack of understanding of how inappropriate use of medicines may
result in AMR. One key informant cautioned that government
officials and other stakeholders should continue creating aware-
ness of AMR to avoid further disastrous effects on human and
animal health: ‘Those who are in the positions to make decisions have
not yet seen how AMR affects our health or animal health, or will cost
us more because more money will be spent on other drugs’ (KI 11:
from Ministry of Livestock and Fisheries).
Limited community engagement was identified as another
weakness in combatting AMR. The study respondents mentioned
that for successful implementation of AMR interventions, com-
munity members who are key stakeholders must be engaged in theinistries as well as from individuals. For example, we work together
ith Tanzania Pharmaceutical Students’ Association to conduct AMR
wareness campaigns’ (KI 7: MCC member from TMDA).
Study participants indicated that Tanzania has an effective
ntimicrobial stewardship programme, which is evidenced by the
xistence of a strong regulatory framework for medicines,4
process. However, it was noted that community engagement in
AMR programmes in many parts of the country is limited. One key
informant underscored that: ‘In the society, we can say there is still a
challenge of ensuring effectively engagement of the community,
because if we want to control AMR, the community must be fully
engaged’ (KII 8: MMC member from ASM).3
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departments from human, animal and environmental health
sectors work in silos, which weakens the efforts to combat
AMR. Although there is a One Health desk housed in the Prime
Minister’s office, the sectors have not coordinated their structures
to work together. For instance, interviewees stated that the
environment sector is not integrated with the human and animal
health sectors in combatting AMR. One of the key informants
expressed that: ‘Each sector is working alone and at the end of the day
you get duplication of efforts. Even in terms of administration, each
one has his/her own leader, which is very challenging’ (KI 9: MCC
member from FAO).
Inadequate human resources in all sectors involved in AMR was
mentioned as another weakness. Execution of AMR activities is
partly hindered by the shortage of staff, particularly in health
facilities, as well as veterinary/livestock extension officers who are
responsible for providing continuous education to dispensers and
consumers of antibiotics. For instance, an observation of the
number of staff working in the pharmacy unit at primary health
facilities showed that most of the dispensing units had only one
staff member present at any time, making it difficult to dispense
drugs while providing education to patients on drug resistance.
Given the shortage of staff, there is limited time to provide
education about AMR to patients while others are waiting: ‘When
we have few clients, we may be able to have adequate time to discuss
with the patient. Some patients don’t understand when you give them
instructions on the use of medicines so you have to repeat several
times’ (KI 17: dispenser from health centre).
3.4. Opportunities
The establishment of the One Health desk, availability of
Guidelines for Surveillance of Prioritised Zoonotic Diseases for
Human and Animal Health of 2018, the development of a
coordinated global surveillance system, and the increased interest
and funding from international sources were identified as the
important opportunities in mitigation of AMR in Tanzania. These
guidelines were developed collaboratively between the
MoHCDGEC Ministry of Livestock and Fisheries and Ministry of
Natural Resources and Tourism. The guidelines provide direction
for effective integrated surveillance and response to priority
zoonoses in Tanzania. The guidelines summarize disease presen-
tation in humans and animals, their documentation, analysis,
interpretation and reporting. They also cover key aspects crucial
for effective surveillance and monitoring and evaluation. These
include community-based surveillance, sharing of data among
sectors, dissemination of information and response. The guidelines
describe the functions of surveillance and users at all levels:
community, district, regional and national. Therefore, they can be
used by all key sectors involved in AMR in conducting surveillance
to strengthen the evidence base on AMR and help inform decision
making and drive national actions.
Study participants reported the existence of a coordinated
global surveillance system whereby WHO member states collect
data on multidrug resistance and feed them into WHONET
software. Study participants reported that different surveillance
sites in Tanzania can collect data on AMR, feed them into WHONET
and get national aggregated data on AMR, which can be used to
inform decision and policy making on antimicrobial use: ‘So, other
national sites have been supported to generate data and feed them
decision and policy making: “The biggest programme that I have to
mention is called ATLASS, which stands for Antimicrobial Laboratory
Surveillance Systems in animals and agriculture, which can be used to
improve country’s surveillance data on AMR’ (KI 9: MCC member
from FAO).
Study participants reported that efforts to combat AMR have
increased interest and funding from local and international
partners willing to invest in interventions targeting AMR in
Tanzania. A development partner official reported that: “An
important component is on investments. A number of stakeholders
are interested to invest and help to get rid of drug resistance in human,
livestock and agriculture’ (KI Number 9, MCC member from FAO).
3.5. Challenges
Inadequate laboratory capacity at the primary healthcare
facility level and financial resource mobilization for AMR
programmes were the two most important challenges identified.
Most of the interviewed laboratory staff reported that most
facilities do not have enough capacity to perform cultures and
antimicrobial susceptibility testing. Generally, inadequate labo-
ratory capacity was reported as one of the challenges for
combatting AMR as expressed by different key informants for
this study: ‘We offer services in different aspects including
haematology tests, full blood picture, parasitology, blood smear
tests, urine analysis, tuberculosis tests, but we don’t carry out culture
test for antibiotic sensitivity tests’ (KI 10: laboratory scientist,
health centre in Dar es Salaam). Another respondent stated that:
‘We don’t have the guidelines for carrying our drug sensitivity and we
don’t do it here’ (KI 16: in-charge of laboratory, health centre in
Kilosa).
Some of the study participants claimed that AMR has become a
critical problem and a burden to the health system in terms of
financial impacts. They explained that the cost of treatment for
people who have a high level of antibiotic resistance is higher than
those who are not infected by drug-resistant pathogens. Given this
situation, respondents mentioned that the inability of government
and other stakeholders to mobilize adequate financial resources to
address AMR is a challenge that needs to be addressed jointly by all
stakeholders: ‘Mobilizing funds is a challenge because not all working
groups have got fund for combatting AMR, so we are still looking for
funds so that we can be able to carry out all AMR activities’ (KI 10:
laboratory scientist, health centre in Dar es Salaam).
4. Discussion
This study used a qualitative approach to explore the AMR
landscape in Tanzania, with semi-structured interviews from
stakeholders at the national and primary health care facility levels.
The themes presented illustrate that there are several strengths for
combatting AMR: improved multisectoral collaboration and
coordination among experts from the animal, human and
environmental health sectors; existence of political commitment;
improved infrastructures; existence of public awareness cam-
paigns emphasizing appropriate use of antimicrobials; and
existence of antimicrobial stewardship. As the fight against AMR
requires efforts of various stakeholders from different sectors
including human and animal health and the environment,
improved multisectoral collaboration and coordination across
these sectors as well as community engagement, were reported asinto a system (WHONET) on monthly basis’ (KI 9: FAO). Participants
also reported on the availability of the FAO Assessment Tool for
Laboratories and AMR Surveillance Systems (FAO-ATLASS) as
another opportunity for addressing AMR in Tanzania. One
participant acknowledged the existence of this tool and its
usefulness in capturing AMR data that can be used to inform44important strengths and key for combatting AMR. The establish-
ment of a MCC in Tanzania has been reported to play an
instrumental role in coordinating various activities regarding
AMR. A study in Guinea, Liberia and Sierra Leone reported similar
findings indicating that in <3 years there has been a remarkable
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A study in Tanzania on building a functional national One
ealth platform reported that the country has a functioning and
nstitutionalized multisectoral coordination mechanism with an
ffective institutional structure and the capacity to prevent, detect
arly and respond to health events [20].
In this study, political commitment and government leadership
ere reported as a strength driving the AMR agenda in terms of
oordination of interventions and mobilization and allocation of
esources. The placement of a One Health office at the Prime
inister’s office is envisaged to facilitate the coordination of AMR
ctivities from other ministries as all of them are answerable to the
ffice. Bhatia et al. [21] insisted that as AMR is a complex,
ultisectoral public health problem, strong political commitment
s important to ensure that there are national and international
ross-sectoral coordination mechanisms that engage all key
takeholders. In Ethiopia, Kenya, the Philippines and Thailand, it
as been shown that political commitment and leadership are
ritical strengths not only in driving the AMR agenda forward but
lso mobilizing and allocating resources for interventions appro-
riately [22]. Political will and support are recognized in different
ountries as instrumental tools in addressing AMR because it is a
orderless threat, which requires global governance and political
trategies to mitigate its emergence and spread [23,24]. However,
ontrary to our findings, it has also been reported that in high-
ncome countries the greatest barriers for combatting AMR are lack
f political support by the whole of government, excessive
ureaucracy and weak implementation procedures, On the other
and, in LMICs political will is often frustrated by inadequate
nfrastructure and human resources, a lack of triangular coopera-
ion and insufficient funding [25].
Findings from this study indicate that having in place improved
nfrastructures is a strength that different actors can use for
ombatting AMR. Study participants acknowledged that different
takeholders such as government and development partners have
oined efforts, which facilitated mobilization of resources includ-
ng funds and laboratory equipment, thereby strengthening
aboratory capacities. Improved laboratory infrastructure in
anzania was critically seen as an important strength, assisting
onfirmatory diagnosis and reducing unnecessary prescription of
ntimicrobials. Further, our work shows that public awareness
ampaigns that emphasize the appropriate use of antimicrobials
re essential for community buy-in to combat AMR. Awareness
reation campaigns have been put in place for key stakeholders
uch as pharmacists, laboratory staff and, to a lesser extent,
ommunities. As in Tanzania, Thailand also acknowledged that
ommunity awareness is an important strength for combatting
MR, leading to the national government adopting a participatory
pproach that engaged with multisectoral stakeholders [26].
Antimicrobial stewardship was acknowledged to be an impor-
ant strength for combatting AMR in this study. Tanzania has put in
lace antimicrobial stewardship interventions including develop-
ent of strong regulatory framework for medicines, guidelines and
 regulatory authority [27]. Analysis indicated that a number of
tewardship programmes have been established to improve
ational use of antimicrobials both in the human and livestock
ectors. These programmes include increasing investments in a
edicines regulatory authority and pharmacy council, in labora-
ory services, and strengthening management teams at all levels of
awareness on AMR among some of the key stakeholders in
different regions, districts and community members. Similar
findings were reported in Singapore where there was low
awareness of AMR among physicians, farmers and others within
the environmental health sector [28]. Mani et al. [29] noted that it
is not possible to make antibiotic resistance prominent on the
policy agenda and attract support from key stakeholders including
civil society organizations if there is limited public awareness on
AMR. Limited awareness on AMR in Tanzania is likely to be a result
of the nature of campaigns that stakeholders have used. These
include the development and dissemination of campaign materials
through channels such as print, television, radio, internet, and
social media, which have some limitations in countries such as
Tanzania in which the majority of people cannot easily access AMR
information through those channels. Factors influencing accessi-
bility of information in Tanzania include literacy levels, income,
reliability of information infrastructure, availability of electricity
and the cost of information and communication technologies [30].
Related to insufficient public awareness on AMR, this study
reported limited community engagement as one of the weaknesses
in combatting AMR. This limited engagement is because most of
the AMR interventions apply a top–down approach whereby the
experts and policy makers in the human, animal and environmen-
tal health sectors are involved in the design of AMR interventions
without engaging community members in the process, thus
limiting the effectiveness of any intervention. In Tanzania, lack of
community engagement in AMR interventions is substantiated by
the existence of unregulated marketing of antimicrobials and
widespread use of antimicrobials as growth promoters in livestock
[15,16,31].
Human, animal and environmental health sectors working in
silos was reported as another weakness in combatting AMR. Across
sectors, cooperation has been complicated by fragmented animal,
public and environmental health systems, leading to reduced
flexibility of actors and their organizations, and resulting in
resource duplication and delays [32]. Although promoting
collaboration between multiple stakeholders is an important
aspect of the One Health approach, there are challenges in ensuring
meaningful and equal participation from diverse actors in multiple
domains and at multiple levels, insufficient policy prioritization
and funding, and the lack of One Health-related educational and
training programmes [33].
Shortages of staff, particularly in the human and animal health
sectors, was discussed as a weakness in combatting AMR. Our key
informants reported that there is inadequate human workforce in
both human and animal healthcare delivery systems, which are
responsible for providing continuous education to consumers of
antimicrobials. Similar findings have been reported elsewhere
[34]. Inadequate laboratory capacity at primary level was also
mentioned as another challenge for combatting AMR. Other
studies on antimicrobial stewardship in Tanzania [27] and Pakistan
[35] have also reported that low capacity of the laboratories in the
primary health facilities limits their ability to combat AMR.
This study identified guidelines that provide direction for
effective integrated surveillance and response to priority zoonoses
in Tanzania. The guidelines also include information on commu-
nity-based surveillance, sharing of data among sectors, dissemi-
nation of information and response. Therefore, they can be used by
all key sectors involved in AMR in conducting AMR surveillance to
strengthen the evidence base on AMR and help inform decisionervice delivery, including medicines and therapeutics commit-
ees; as well as strengthening advocacy on rational use of
ntimicrobials [27].
Apart from opportunities offered by the One Health approach in
ackling AMR, this study has identified a number of weaknesses in
ow Tanzania is addressing the AMR threat. There is limited4
making and drive national actions. The establishment of the Africa
Centers for Disease Control and Prevention’s Antimicrobial
Resistance and Surveillance Network was also recognized as an
opportunity for standardizing the approach to AMR surveillance
and attempt to attain good-quality data [36]. In addition, the
existence of a coordinated global surveillance system like5
G. Frumence, L.E.G. Mboera, B.Z. Katale et al. Journal of Global Antimicrobial Resistance 25 (2021) 40–47WHONET has also been listed as one way in which countries such
as Tanzania can generate national aggregated data on AMR for
informing policy and decision making on antimicrobial use [37].
Increased interest and funding from local and international
partners for combatting AMR provide further opportunity for
Tanzania to address the AMR challenges. A number of stakeholders,
through investments in innovation, have contributed to an increased
effort in investing in different AMR priority areas including research
and development [38]. The World Bank is also financing improve-
ments in disease surveillance and laboratory strengthening in
multiple countries to consolidate the core functions of human and
animal public health systems to combat global public health threats
including AMR [39]. Despite the fact that this study reported an
increased interest in funding AMR-related activities, this is also a
challenge because the level of funding from international sources
may not necessarily meet local needs and is unlikely to be
sustainable. In spite of mounting evidence on the impact of AMR
and multiple calls for action and interventions to combat AMR,
funding has remained inadequate at all levels, making it difficult for
various nations to address this problem [40].
The strengths of this paper are that it is one of the first
qualitative studies to explore in detail the perceptions of policy
makers and practitioners on the strengths, weaknesses, oppor-
tunities and challenges of implementing AMR NAPs, and that the
interpretation of the findings is grounded in interviewees’ or
respondents’ contributions. Social desirability bias was a limitation
of this research in which some members had a tendency to present
reality in line with what they believe to be socially acceptable.
However, this limitation was mitigated during data collection,
whereby researchers clearly introduced the study objectives and
established rapport with the participants.
In summary, this study has identified several areas that should be
addressed in future policies on AMR. These include among others:
enhancement of public awareness of AMR and community engage-
ment, deployment of adequate human resources to combat AMR,
upgrading of laboratory capacity at primary-level health facilities
and ensuring adequate resource mobilization to meet AMR needs.
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